Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Drug & Device News

By ALM Staff | Law Journal Newsletters |
November 02, 2014

Appeals Court Upholds $10 Million Motrin Verdict

Pennsylvania's Superior Court has upheld a $10 million verdict against pharmaceuticals manufacturer McNeil-PPC compensating a child who was injured after taking Children's Motrin. The Philadelphia Court of Common Pleas jury that heard the case concluded that McNeil-PPC, a subsidiary of Johnson & Johnson, failed to adequately warn the parents of the then-three-year-old girl of the risks of giving their child the over-the-counter product, resulting in damage to her reproductive system, permanent disfigurement of her skin and loss of sight in her left eye. On appeal, the pharmaceuticals company argued that negligence had not been proven because the Children's Motrin warning label contained all the cautionary information required of and approved by the U.S. Food and Drug Administration (FDA) ' and this information did not included warnings about rashes, blisters or skin reddening. Relying on Daniel v. Wyeth Pharmaceuticals, Judge Kate Ford Elliott wrote that the appellants could not shield themselves behind a federal preemption argument, but must take responsibility for providing adequate warning information on its product's label. In addition, although the injured child's mother testified that she would have relied on the girl's doctor's recommendation that she give Children's Motrin even if the label had warned of blisters or rashes, she also testified that she would have discontinued its use once her child developed these symptoms if such warnings had existed. “Therefore,” Judge Ford Elliott wrote, the manufacturer's argument that failure-to-warn did not cause the child harm must fail, as “there was testimony that an adequate warning would have prevented [the child] from receiving the last four or five doses of Children's Motrin.” This, along with expert testimony that the child's injuries would have been fewer had she stopped taking the drug sooner, supported a finding that the company was liable.

This premium content is locked for Entertainment Law & Finance subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
New York's Latest Cybersecurity Commitment Image

On Aug. 9, 2023, Gov. Kathy Hochul introduced New York's inaugural comprehensive cybersecurity strategy. In sum, the plan aims to update government networks, bolster county-level digital defenses, and regulate critical infrastructure.

Law Firms are Reducing Redundant Real Estate by Bringing Support Services Back to the Office Image

A trend analysis of the benefits and challenges of bringing back administrative, word processing and billing services to law offices.

Bit Parts Image

Summary Judgment Denied Defendant in Declaratory Action by Producer of To Kill a Mockingbird Broadway Play Seeking Amateur Theatrical Rights

The Bankruptcy Hotline Image

Recent cases of importance to your practice.

Risks of “Baseball Arbitration” in Resolving Real Estate Disputes Image

“Baseball arbitration” refers to the process used in Major League Baseball in which if an eligible player's representative and the club ownership cannot reach a compensation agreement through negotiation, each party enters a final submission and during a formal hearing each side — player and management — presents its case and then the designated panel of arbitrators chooses one of the salary bids with no other result being allowed. This method has become increasingly popular even beyond the sport of baseball.